ABI
ATHN

Adamant Biomedical Investments’s Athenahealth, Inc. ATHN Stock Holding History

Adamant Biomedical Investments’s Portfolio ATHN Stock Details ATHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$1.46M Hold
10,000
– – 0.35% 75
2014
Q3 		$1.32M Buy
+10,000
New +$1.32M 0.33% 73

Other funds holding ATHN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Adamant Biomedical Investments's ATHN Position: Q4 2014 in Review

Adamant Biomedical Investments held its Athenahealth, Inc. (ATHN) position steady in Q4 2014 at 10,000 shares worth $1.46M. The position accounts for 0.35% of the portfolio, ranked #75.

Adamant Biomedical Investments first reported a position in ATHN in Q3 2014 and has held it in 2 quarters since. 205 funds tracked by Wall St. Rank hold ATHN as of Q4 2014.

  • Adamant Biomedical Investments held 10,000 shares of Athenahealth, Inc. worth $1.46M as of Q4 2014.
  • Adamant Biomedical Investments left its Athenahealth, Inc. share count unchanged in Q4 2014.
  • Athenahealth, Inc. made up 0.35% of Adamant Biomedical Investments's portfolio in Q4 2014, its #75 holding.
  • Adamant Biomedical Investments first reported a position in Athenahealth, Inc. in Q3 2014 and has held it in 2 quarters since.
  • 205 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.